PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
PROCEPT BioRobotics (Nasdaq: PRCT), a surgical robotics company specializing in urology solutions, has announced its participation in four major investor conferences during May and June 2025.
The conference schedule includes:
- Bank of America Health Care Conference in Las Vegas - Fireside Chat on May 14
- William Blair Growth Stock Conference in Chicago - Presentation on June 4
- Jefferies Global Healthcare Conference in New York City - Fireside Chat on June 5
- Truist Med-Tech Conference in Boston - Fireside Chat on June 17
All events will be accessible via live webcast through the company's investor relations website, with recordings available for replay up to 90 days after each event.
PROCEPT BioRobotics (Nasdaq: PRCT), azienda di robotica chirurgica specializzata in soluzioni per l'urologia, ha annunciato la sua partecipazione a quattro importanti conferenze per investitori nei mesi di maggio e giugno 2025.
Il calendario delle conferenze prevede:
- Bank of America Health Care Conference a Las Vegas - Fireside Chat il 14 maggio
- William Blair Growth Stock Conference a Chicago - Presentazione il 4 giugno
- Jefferies Global Healthcare Conference a New York City - Fireside Chat il 5 giugno
- Truist Med-Tech Conference a Boston - Fireside Chat il 17 giugno
Tutti gli eventi saranno accessibili tramite webcast in diretta sul sito dedicato agli investitori dell'azienda, con le registrazioni disponibili per la visione fino a 90 giorni dopo ogni evento.
PROCEPT BioRobotics (Nasdaq: PRCT), una empresa de robótica quirúrgica especializada en soluciones urológicas, ha anunciado su participación en cuatro importantes conferencias para inversores durante mayo y junio de 2025.
El calendario de conferencias incluye:
- Bank of America Health Care Conference en Las Vegas - Fireside Chat el 14 de mayo
- William Blair Growth Stock Conference en Chicago - Presentación el 4 de junio
- Jefferies Global Healthcare Conference en Nueva York - Fireside Chat el 5 de junio
- Truist Med-Tech Conference en Boston - Fireside Chat el 17 de junio
Todos los eventos estarán disponibles mediante webcast en vivo a través del sitio web de relaciones con inversores de la compañía, con grabaciones accesibles para reproducción hasta 90 días después de cada evento.
PROCEPT BioRobotics (나스닥: PRCT)는 비뇨기과 솔루션에 특화된 수술용 로봇 회사로, 2025년 5월과 6월에 열리는 주요 투자자 컨퍼런스 네 곳에 참여한다고 발표했습니다.
컨퍼런스 일정은 다음과 같습니다:
- Bank of America Health Care Conference 라스베이거스 - 5월 14일 파이어사이드 채팅
- William Blair Growth Stock Conference 시카고 - 6월 4일 발표
- Jefferies Global Healthcare Conference 뉴욕시티 - 6월 5일 파이어사이드 채팅
- Truist Med-Tech Conference 보스턴 - 6월 17일 파이어사이드 채팅
모든 행사는 회사 투자자 관계 웹사이트를 통해 라이브 웹캐스트로 시청할 수 있으며, 각 행사 후 최대 90일간 녹화 영상을 다시 볼 수 있습니다.
PROCEPT BioRobotics (Nasdaq : PRCT), une entreprise de robotique chirurgicale spécialisée dans les solutions urologiques, a annoncé sa participation à quatre grandes conférences pour investisseurs en mai et juin 2025.
Le calendrier des conférences comprend :
- Bank of America Health Care Conference à Las Vegas - Fireside Chat le 14 mai
- William Blair Growth Stock Conference à Chicago - Présentation le 4 juin
- Jefferies Global Healthcare Conference à New York City - Fireside Chat le 5 juin
- Truist Med-Tech Conference à Boston - Fireside Chat le 17 juin
Tous les événements seront accessibles en webcast en direct via le site des relations investisseurs de la société, avec des enregistrements disponibles en replay jusqu’à 90 jours après chaque événement.
PROCEPT BioRobotics (Nasdaq: PRCT), ein Unternehmen für chirurgische Robotik mit Schwerpunkt auf urologischen Lösungen, hat seine Teilnahme an vier bedeutenden Investorenkonferenzen im Mai und Juni 2025 angekündigt.
Der Konferenzplan umfasst:
- Bank of America Health Care Conference in Las Vegas – Fireside Chat am 14. Mai
- William Blair Growth Stock Conference in Chicago – Präsentation am 4. Juni
- Jefferies Global Healthcare Conference in New York City – Fireside Chat am 5. Juni
- Truist Med-Tech Conference in Boston – Fireside Chat am 17. Juni
Alle Veranstaltungen sind über einen Live-Webcast auf der Investor-Relations-Website des Unternehmens zugänglich, mit Aufzeichnungen, die bis zu 90 Tage nach jedem Event zum Nachsehen bereitstehen.
- High-profile investor exposure through participation in four major healthcare/investment conferences
- Management's active engagement in investor relations through fireside chats and presentations
- Strong institutional backing evidenced by participation in conferences hosted by major firms like Bank of America, William Blair, Jefferies, and Truist
- None.
SAN JOSE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members of management will present at four upcoming investor conferences in May and June.
2025 Bank of America Health Care Conference
- Location – Las Vegas, NV
- Fireside Chat – Wednesday, May 14 at 3pm PT / 6pm ET
45th Annual William Blair Growth Stock Conference
- Location – Chicago, IL
- Presentation – Wednesday, June 4 at 10am CT / 11am ET
2025 Jefferies Global Healthcare Conference
- Location – New York City, NY
- Fireside Chat – Thursday, June 5 at 8:45m ET
2025 Truist Med-Tech Conference
- Location – Boston, MA
- Fireside Chat – Tuesday, June 17 at 8:40am ET
A live webcast of each event, as well as an archived recording, will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com. The webcasts will be archived and available for replay for at least 90 days after the event.
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics’ mission is to revolutionize BPH treatment globally in partnership with urologists by delivering best-in-class robotic solutions that positively impact patients and drive value. PROCEPT BioRobotics manufactures the AQUABEAM® and HYDROS™ Robotic Systems. The HYDROS Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.
Investor Contact:
Matt Bacso
VP, Investor Relations and Business Operations
m.bacso@procept-biorobotics.com
